Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Transport Proteins | 7 | 2017 | 178 | 2.150 |
Why?
|
| Bacterial Proteins | 10 | 2020 | 944 | 1.950 |
Why?
|
| Stearoyl-CoA Desaturase | 3 | 2023 | 11 | 1.880 |
Why?
|
| Models, Molecular | 22 | 2021 | 1061 | 1.870 |
Why?
|
| Cryoelectron Microscopy | 6 | 2024 | 244 | 1.690 |
Why?
|
| Iron | 7 | 2023 | 306 | 1.670 |
Why?
|
| Potassium Channels | 7 | 2020 | 153 | 1.630 |
Why?
|
| Copper Radioisotopes | 4 | 2018 | 6 | 1.190 |
Why?
|
| Crystallography, X-Ray | 15 | 2020 | 364 | 1.150 |
Why?
|
| Sulfides | 3 | 2015 | 21 | 1.020 |
Why?
|
| Metal Nanoparticles | 3 | 2018 | 54 | 1.020 |
Why?
|
| Protein Structure, Tertiary | 6 | 2015 | 715 | 1.000 |
Why?
|
| Cation Transport Proteins | 3 | 2023 | 101 | 0.990 |
Why?
|
| Binding Sites | 12 | 2023 | 1136 | 0.970 |
Why?
|
| Shaker Superfamily of Potassium Channels | 4 | 2012 | 31 | 0.950 |
Why?
|
| Electrons | 2 | 2023 | 25 | 0.950 |
Why?
|
| Copper | 5 | 2018 | 69 | 0.920 |
Why?
|
| Low-Level Light Therapy | 2 | 2016 | 19 | 0.900 |
Why?
|
| Protein Conformation | 10 | 2020 | 732 | 0.830 |
Why?
|
| Ion Channel Gating | 6 | 2014 | 120 | 0.820 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 1 | 2023 | 2 | 0.790 |
Why?
|
| Cations, Divalent | 1 | 2023 | 19 | 0.790 |
Why?
|
| Biocatalysis | 1 | 2023 | 37 | 0.790 |
Why?
|
| Eukaryotic Cells | 1 | 2023 | 29 | 0.790 |
Why?
|
| Cytochromes b5 | 2 | 2020 | 3 | 0.760 |
Why?
|
| Nanoparticles | 3 | 2020 | 299 | 0.760 |
Why?
|
| Cytochromes b | 1 | 2022 | 5 | 0.760 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 156 | 0.720 |
Why?
|
| Oxidoreductases | 4 | 2023 | 105 | 0.720 |
Why?
|
| Hepcidins | 2 | 2023 | 26 | 0.700 |
Why?
|
| Symporters | 1 | 2022 | 80 | 0.700 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 2 | 2018 | 7 | 0.690 |
Why?
|
| Anion Transport Proteins | 1 | 2021 | 31 | 0.690 |
Why?
|
| Cell Membrane | 4 | 2016 | 451 | 0.680 |
Why?
|
| Cortisone | 2 | 2012 | 11 | 0.660 |
Why?
|
| Arabidopsis Proteins | 1 | 2021 | 59 | 0.660 |
Why?
|
| Glucose | 2 | 2016 | 852 | 0.650 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2020 | 192 | 0.650 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2020 | 4 | 0.650 |
Why?
|
| Protein Binding | 8 | 2020 | 1656 | 0.650 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 3 | 0.650 |
Why?
|
| Arabidopsis | 1 | 2021 | 93 | 0.640 |
Why?
|
| Animals | 28 | 2024 | 33857 | 0.630 |
Why?
|
| Membrane Potentials | 3 | 2020 | 293 | 0.620 |
Why?
|
| Vibrio parahaemolyticus | 3 | 2020 | 7 | 0.600 |
Why?
|
| Escherichia coli Proteins | 2 | 2020 | 316 | 0.590 |
Why?
|
| Biological Transport | 4 | 2022 | 329 | 0.550 |
Why?
|
| Urea | 3 | 2014 | 219 | 0.540 |
Why?
|
| Heme | 2 | 2023 | 46 | 0.540 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 288 | 0.520 |
Why?
|
| Mammals | 3 | 2023 | 251 | 0.520 |
Why?
|
| Bacillus cereus | 3 | 2018 | 9 | 0.520 |
Why?
|
| Liposomes | 2 | 2015 | 197 | 0.510 |
Why?
|
| Coordination Complexes | 1 | 2016 | 9 | 0.500 |
Why?
|
| Laser Therapy | 2 | 2018 | 241 | 0.490 |
Why?
|
| Thermography | 1 | 2016 | 12 | 0.490 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 422 | 0.480 |
Why?
|
| Structure-Activity Relationship | 5 | 2020 | 553 | 0.480 |
Why?
|
| Metals | 1 | 2016 | 67 | 0.480 |
Why?
|
| Oxygen | 2 | 2016 | 550 | 0.480 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 1216 | 0.470 |
Why?
|
| NADP | 3 | 2023 | 55 | 0.450 |
Why?
|
| Antigens, Neoplasm | 2 | 2023 | 393 | 0.450 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2015 | 23 | 0.450 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2015 | 19 | 0.450 |
Why?
|
| Kidney | 3 | 2012 | 1278 | 0.450 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2014 | 4 | 0.430 |
Why?
|
| Protein Multimerization | 3 | 2021 | 149 | 0.430 |
Why?
|
| Potassium | 3 | 2020 | 266 | 0.420 |
Why?
|
| Escherichia coli | 1 | 2020 | 991 | 0.410 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 219 | 0.410 |
Why?
|
| Yersinia | 1 | 2013 | 5 | 0.410 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 154 | 0.400 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 2599 | 0.370 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 157 | 0.360 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 249 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 585 | 0.360 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 409 | 0.350 |
Why?
|
| Ion Transport | 3 | 2020 | 48 | 0.350 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2011 | 39 | 0.350 |
Why?
|
| Aldehyde Reductase | 2 | 2008 | 18 | 0.330 |
Why?
|
| Substrate Specificity | 4 | 2016 | 285 | 0.320 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 613 | 0.320 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 137 | 0.320 |
Why?
|
| Desulfovibrio vulgaris | 1 | 2009 | 1 | 0.310 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 334 | 0.310 |
Why?
|
| Mice, Nude | 3 | 2016 | 698 | 0.310 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2397 | 0.310 |
Why?
|
| Electron Transport | 2 | 2022 | 60 | 0.300 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2008 | 18 | 0.290 |
Why?
|
| Static Electricity | 2 | 2021 | 44 | 0.280 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1000 | 0.280 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2006 | 63 | 0.270 |
Why?
|
| Molecular Conformation | 2 | 2022 | 96 | 0.270 |
Why?
|
| Acyl Coenzyme A | 2 | 2020 | 23 | 0.270 |
Why?
|
| Protein Structure, Quaternary | 4 | 2013 | 92 | 0.270 |
Why?
|
| Mice | 10 | 2020 | 18229 | 0.260 |
Why?
|
| Hyperthermia, Induced | 3 | 2016 | 51 | 0.260 |
Why?
|
| Protein Domains | 2 | 2020 | 252 | 0.260 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 434 | 0.260 |
Why?
|
| Catalytic Domain | 2 | 2020 | 159 | 0.250 |
Why?
|
| Adenosine Diphosphate | 2 | 2020 | 48 | 0.250 |
Why?
|
| Phosphorylation | 3 | 2018 | 1571 | 0.250 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2018 | 125 | 0.250 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2006 | 18 | 0.240 |
Why?
|
| HEK293 Cells | 3 | 2020 | 805 | 0.240 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 267 | 0.240 |
Why?
|
| Xenopus laevis | 3 | 2012 | 112 | 0.230 |
Why?
|
| Humans | 23 | 2024 | 130436 | 0.230 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1547 | 0.230 |
Why?
|
| Phototherapy | 2 | 2015 | 37 | 0.230 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 3469 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 3717 | 0.220 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 1317 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3749 | 0.210 |
Why?
|
| Ions | 1 | 2004 | 25 | 0.210 |
Why?
|
| Rats | 6 | 2016 | 3371 | 0.210 |
Why?
|
| Goiter, Nodular | 1 | 2024 | 3 | 0.210 |
Why?
|
| Halogens | 1 | 2024 | 4 | 0.210 |
Why?
|
| Polyethylene Glycols | 4 | 2023 | 232 | 0.210 |
Why?
|
| Bicarbonates | 1 | 2024 | 98 | 0.200 |
Why?
|
| Carbohydrate Metabolism | 2 | 2016 | 50 | 0.200 |
Why?
|
| Chlorides | 1 | 2024 | 97 | 0.200 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2023 | 4 | 0.200 |
Why?
|
| Phosphotransferases | 1 | 2023 | 33 | 0.200 |
Why?
|
| Phosphatidylcholines | 1 | 2023 | 34 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 623 | 0.200 |
Why?
|
| Catalysis | 1 | 2023 | 138 | 0.190 |
Why?
|
| Receptors, Cholinergic | 2 | 2000 | 26 | 0.190 |
Why?
|
| Hemochromatosis | 1 | 2023 | 39 | 0.190 |
Why?
|
| Peptide Transporter 1 | 1 | 2022 | 1 | 0.190 |
Why?
|
| Oocytes | 4 | 2009 | 282 | 0.180 |
Why?
|
| Mutagenesis | 2 | 2020 | 325 | 0.180 |
Why?
|
| Xenopus | 4 | 2008 | 103 | 0.180 |
Why?
|
| Horses | 1 | 2022 | 93 | 0.180 |
Why?
|
| Sulfates | 1 | 2021 | 32 | 0.170 |
Why?
|
| Amines | 1 | 2001 | 35 | 0.170 |
Why?
|
| Prostate | 1 | 2023 | 400 | 0.170 |
Why?
|
| Potassium Channel Blockers | 1 | 2001 | 84 | 0.170 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2018 | 79 | 0.170 |
Why?
|
| Protein Folding | 2 | 2013 | 215 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2023 | 373 | 0.160 |
Why?
|
| Molecular Structure | 2 | 2014 | 313 | 0.160 |
Why?
|
| Sf9 Cells | 1 | 2020 | 10 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2021 | 193 | 0.160 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 780 | 0.160 |
Why?
|
| Kinetics | 2 | 2016 | 1084 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 398 | 0.160 |
Why?
|
| Diglycerides | 1 | 2020 | 16 | 0.160 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 272 | 0.160 |
Why?
|
| Swine | 1 | 2024 | 1184 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 372 | 0.160 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 22 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 38 | 0.160 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 99 | 0.160 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 50 | 0.150 |
Why?
|
| Peptides | 2 | 2022 | 704 | 0.150 |
Why?
|
| Zinc | 1 | 2020 | 128 | 0.150 |
Why?
|
| Choline | 1 | 1999 | 48 | 0.150 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 31 | 0.150 |
Why?
|
| Electrophysiology | 2 | 2011 | 249 | 0.150 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2018 | 15 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 143 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 139 | 0.140 |
Why?
|
| Predatory Behavior | 1 | 2018 | 6 | 0.140 |
Why?
|
| KCNQ Potassium Channels | 1 | 2018 | 10 | 0.140 |
Why?
|
| Arthropod Venoms | 1 | 2018 | 7 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 200 | 0.140 |
Why?
|
| Arthropods | 1 | 2018 | 23 | 0.130 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2018 | 69 | 0.130 |
Why?
|
| Calcium | 1 | 2023 | 1022 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2020 | 517 | 0.130 |
Why?
|
| Cysteine | 1 | 2018 | 137 | 0.130 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 42 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2896 | 0.130 |
Why?
|
| Triglycerides | 1 | 2020 | 602 | 0.130 |
Why?
|
| Cell Line | 4 | 2016 | 2557 | 0.130 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2016 | 18 | 0.130 |
Why?
|
| Biochemical Phenomena | 1 | 2016 | 3 | 0.130 |
Why?
|
| Biophysical Phenomena | 1 | 2016 | 39 | 0.130 |
Why?
|
| Circular Dichroism | 1 | 2016 | 62 | 0.130 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2016 | 23 | 0.120 |
Why?
|
| Melanoma | 1 | 2023 | 926 | 0.120 |
Why?
|
| Gold | 1 | 2016 | 54 | 0.120 |
Why?
|
| Rabbits | 1 | 2016 | 573 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2016 | 116 | 0.120 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 160 | 0.110 |
Why?
|
| Syk Kinase | 1 | 2015 | 17 | 0.110 |
Why?
|
| Histidine | 1 | 2015 | 69 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 110 | 0.110 |
Why?
|
| Radiotherapy | 1 | 2015 | 120 | 0.110 |
Why?
|
| Protein Transport | 1 | 2016 | 367 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2016 | 288 | 0.110 |
Why?
|
| Photoacoustic Techniques | 1 | 2014 | 6 | 0.110 |
Why?
|
| Archaeoglobus fulgidus | 1 | 2014 | 2 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2015 | 99 | 0.110 |
Why?
|
| Magnesium | 1 | 2014 | 114 | 0.100 |
Why?
|
| Rotation | 1 | 2013 | 34 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 395 | 0.100 |
Why?
|
| Electric Conductivity | 1 | 2013 | 80 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 331 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 713 | 0.100 |
Why?
|
| Fluticasone | 1 | 2012 | 16 | 0.090 |
Why?
|
| Mutation | 4 | 2017 | 6098 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2016 | 384 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1000 | 0.090 |
Why?
|
| Osmosis | 1 | 2012 | 17 | 0.090 |
Why?
|
| Sodium | 1 | 2013 | 278 | 0.090 |
Why?
|
| Androstadienes | 1 | 2012 | 50 | 0.090 |
Why?
|
| Metabolism | 1 | 2012 | 45 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 977 | 0.090 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 260 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 162 | 0.080 |
Why?
|
| Crystallization | 1 | 2011 | 83 | 0.080 |
Why?
|
| Cattle | 1 | 2012 | 502 | 0.080 |
Why?
|
| Contrast Media | 1 | 2014 | 474 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 132 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 79 | 0.080 |
Why?
|
| Ligands | 1 | 2012 | 482 | 0.080 |
Why?
|
| DNA Primers | 1 | 2011 | 600 | 0.080 |
Why?
|
| Algorithms | 1 | 2016 | 1663 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2088 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2009 | 158 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2011 | 934 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2008 | 140 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1456 | 0.070 |
Why?
|
| Streptomyces lividans | 1 | 2007 | 1 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2011 | 897 | 0.070 |
Why?
|
| Cations | 1 | 2007 | 38 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 116 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 970 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 1008 | 0.060 |
Why?
|
| Female | 5 | 2020 | 70351 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2008 | 576 | 0.060 |
Why?
|
| Aldo-Keto Reductases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1363 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1693 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 196 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2008 | 767 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 809 | 0.050 |
Why?
|
| Rubidium | 1 | 2004 | 3 | 0.050 |
Why?
|
| Ipilimumab | 1 | 2023 | 63 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2023 | 236 | 0.050 |
Why?
|
| Point Mutation | 2 | 2000 | 332 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 33 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2001 | 583 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12834 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 46 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 713 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2018 | 29 | 0.030 |
Why?
|
| Carbamates | 1 | 2018 | 63 | 0.030 |
Why?
|
| Transfection | 1 | 1999 | 960 | 0.030 |
Why?
|
| Phosphatidylglycerols | 1 | 2017 | 9 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4667 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 22 | 0.030 |
Why?
|
| Maltose | 1 | 2017 | 16 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 2017 | 44 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2017 | 85 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 410 | 0.030 |
Why?
|
| Male | 3 | 2023 | 64471 | 0.030 |
Why?
|
| Ethiodized Oil | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nanospheres | 1 | 2016 | 6 | 0.030 |
Why?
|
| Syndrome | 1 | 1999 | 1158 | 0.030 |
Why?
|
| Stilbenes | 1 | 2016 | 35 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1314 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 501 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 414 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2018 | 362 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 759 | 0.030 |
Why?
|
| Thermodynamics | 2 | 2007 | 145 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1104 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1807 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 1618 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2007 | 45 | 0.020 |
Why?
|
| Calorimetry | 1 | 2007 | 63 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2007 | 89 | 0.020 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2000 | 3 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2000 | 4 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 129 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 2000 | 58 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28395 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 202 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 250 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31120 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 692 | 0.010 |
Why?
|